Rad AI Stock
HealthTechLooking to sell Rad AI stock or options?
Rad AI is the developer of a generative artificial intelligence solution platform designed to streamline healthcare workflows, save time for providers, and reduce burnout. The company's platform enhances workflow efficiency by integrating seamlessly with existing processes, automating repetitive and time-consuming tasks, and boosting overall productivity. This enables radiologists to improve their workflows, maximizing both efficiency and accuracy while decreasing patient turnaround time.
Renn Ventures, ARTIS Ventures, Harmonix Fund, Fifty Years, Hike Ventures, Khosla Ventures, Calm Ventures, OCV Partners, Hyperlink Ventures, Santa Barbara Venture Partners, Impact Assets, UP2398, Precursor Ventures, GMO Venture Partners, Alpha Partners, Kickstart Fund, PROOF, Gaingels, Gradient Ventures, Esplanade Healthtech Ventures, Gannett Partners, WiL (World Innovation Lab), City Light Capital, Array Ventures.
Our available services for this company
Management Team
Board Members
Rad AI’s stock FAQs
Rad AI is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Rad AI stock. Depending on Rad AI’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Rad AI stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Rad AI stock in two ways. First, Rad AI employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Rad AI stock. Note that all transactions in Rad AI shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Rad AI stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Rad AI stock. Typically, shares of private companies like Rad AI are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On May 2024, Rad AI is reported to have closed an equity financing in which the investors valued the company at $276M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Rad AI shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Rad AI is not currently publicly traded, it does not have a ticker symbol.
Rad AI has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Rad AI is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Rad AI shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
